ATYPICAL FIBROXANTHOMA

Clinical trials for ATYPICAL FIBROXANTHOMA explained in plain language.

Never miss a new study

Get alerted when new ATYPICAL FIBROXANTHOMA trials appear

Sign up with your email to follow new studies for ATYPICAL FIBROXANTHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for kids with rare sarcoma: targeted drugs and smarter radiation on trial

Disease control Recruiting now

This study is for children and young adults (up to age 30) with a rare type of soft tissue cancer called non-rhabdomyosarcoma. It tests whether adding the targeted drug pazopanib (and another drug, selinexor, for high-risk patients) to standard chemotherapy and radiation can impr…

Matched conditions: ATYPICAL FIBROXANTHOMA

Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control

Last updated May 15, 2026 11:55 UTC

ATYPICAL FIBROXANTHOMA

Get alerted when new ATYPICAL FIBROXANTHOMA trials appear

New hope for kids with rare sarcoma: targeted drugs and smarter radiation on trial